Advanced search
1 file | 659.90 KB Add to list

Invariant natural killer T cells in rheumatic disease : a joint dilemma

Michael Drennan (UGent) , SANDRINE ASPESLAGH (UGent) and Dirk Elewaut (UGent)
Author
Organization
Abstract
Invariant natural killer T (iNKT) cells are an innate T-cell lineage known to recognize a range of endogenously derived and exogenously derived glycolipid antigens. Advances in our understanding of this T-cell subset have enabled researchers to investigate the immunomodulatory activity of iNKT cell ligands in experimental models of diseases such as cancer, allergy and chronic inflammatory joint disease. To a large extent, the ability of iNKT cells to regulate such disease models has been ascribed to their capacity to promote a polarized cytokine environment, which is understood to skew adaptive immune responses. In this Review, we discuss the current understanding of how iNKT-cell polarization is regulated and relate this basic theory to the proposed role for iNKT cells in models of rheumatologic disease.
Keywords
INNATE IMMUNE-RESPONSE, TOLL-LIKE RECEPTORS, COLLAGEN-INDUCED ARTHRITIS, LIGAND ALPHA-GALACTOSYLCERAMIDE, INITIATE CONTACT SENSITIVITY, V-ALPHA-14 NKT CELLS, CUTTING EDGE, DENDRITIC CELLS, SYSTEMIC-LUPUS-ERYTHEMATOSUS, MRL-LPR/LPR MICE

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 659.90 KB

Citation

Please use this url to cite or link to this publication:

MLA
Drennan, Michael, et al. “Invariant Natural Killer T Cells in Rheumatic Disease : A Joint Dilemma.” NATURE REVIEWS RHEUMATOLOGY, vol. 6, no. 2, 2010, pp. 90–98, doi:10.1038/nrrheum.2009.261.
APA
Drennan, M., ASPESLAGH, S., & Elewaut, D. (2010). Invariant natural killer T cells in rheumatic disease : a joint dilemma. NATURE REVIEWS RHEUMATOLOGY, 6(2), 90–98. https://doi.org/10.1038/nrrheum.2009.261
Chicago author-date
Drennan, Michael, SANDRINE ASPESLAGH, and Dirk Elewaut. 2010. “Invariant Natural Killer T Cells in Rheumatic Disease : A Joint Dilemma.” NATURE REVIEWS RHEUMATOLOGY 6 (2): 90–98. https://doi.org/10.1038/nrrheum.2009.261.
Chicago author-date (all authors)
Drennan, Michael, SANDRINE ASPESLAGH, and Dirk Elewaut. 2010. “Invariant Natural Killer T Cells in Rheumatic Disease : A Joint Dilemma.” NATURE REVIEWS RHEUMATOLOGY 6 (2): 90–98. doi:10.1038/nrrheum.2009.261.
Vancouver
1.
Drennan M, ASPESLAGH S, Elewaut D. Invariant natural killer T cells in rheumatic disease : a joint dilemma. NATURE REVIEWS RHEUMATOLOGY. 2010;6(2):90–8.
IEEE
[1]
M. Drennan, S. ASPESLAGH, and D. Elewaut, “Invariant natural killer T cells in rheumatic disease : a joint dilemma,” NATURE REVIEWS RHEUMATOLOGY, vol. 6, no. 2, pp. 90–98, 2010.
@article{1985148,
  abstract     = {{Invariant natural killer T (iNKT) cells are an innate T-cell lineage known to recognize a range of endogenously derived and exogenously derived glycolipid antigens. Advances in our understanding of this T-cell subset have enabled researchers to investigate the immunomodulatory activity of iNKT cell ligands in experimental models of diseases such as cancer, allergy and chronic inflammatory joint disease. To a large extent, the ability of iNKT cells to regulate such disease models has been ascribed to their capacity to promote a polarized cytokine environment, which is understood to skew adaptive immune responses. In this Review, we discuss the current understanding of how iNKT-cell polarization is regulated and relate this basic theory to the proposed role for iNKT cells in models of rheumatologic disease.}},
  author       = {{Drennan, Michael and ASPESLAGH, SANDRINE and Elewaut, Dirk}},
  issn         = {{1759-4790}},
  journal      = {{NATURE REVIEWS RHEUMATOLOGY}},
  keywords     = {{INNATE IMMUNE-RESPONSE,TOLL-LIKE RECEPTORS,COLLAGEN-INDUCED ARTHRITIS,LIGAND ALPHA-GALACTOSYLCERAMIDE,INITIATE CONTACT SENSITIVITY,V-ALPHA-14 NKT CELLS,CUTTING EDGE,DENDRITIC CELLS,SYSTEMIC-LUPUS-ERYTHEMATOSUS,MRL-LPR/LPR MICE}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{90--98}},
  title        = {{Invariant natural killer T cells in rheumatic disease : a joint dilemma}},
  url          = {{http://dx.doi.org/10.1038/nrrheum.2009.261}},
  volume       = {{6}},
  year         = {{2010}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: